136 related articles for article (PubMed ID: 23077982)
1. Cardioembolic stroke in patients with patent foramen ovale and implanted cardiac leads.
DeSimone CV; DeSimone DC; Hagler DJ; Friedman PA; Asirvatham SJ
Pacing Clin Electrophysiol; 2013 Jan; 36(1):50-4. PubMed ID: 23077982
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardiac devices with patent foramen ovale--a risk factor for cardioembolic stroke?
DeSimone CV; DeSimone DC; Patel NA; Friedman PA; Asirvatham SJ
J Interv Card Electrophysiol; 2012 Nov; 35(2):159-62. PubMed ID: 22869390
[TBL] [Abstract][Full Text] [Related]
3. Occlusion of PFO with a dedicated adjustable device: influence on one year outcome.
Kleber FX; Winkelmann A; Stretz A; Sonntag SM; Bruch L; Rademacher G; Sparenberg P; Schmehl I
EuroIntervention; 2010 Aug; 6(3):367-70. PubMed ID: 20884416
[TBL] [Abstract][Full Text] [Related]
4. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale (PFO) closure to prevent recurrent stroke in a patient with a nickel allergy.
Rizvi AA; Margey R; Kiernan F
Conn Med; 2014 Apr; 78(4):215-9. PubMed ID: 24830118
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Stroke due to Patent Foramen Ovale Closure Device Thrombus Eight Years after Implantation.
Kodankandath TV; Mishra S; Libman RB; Wright P
J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):e161-2. PubMed ID: 27444520
[TBL] [Abstract][Full Text] [Related]
7. Patent foramen ovale--assessment and treatment.
Irwin B; Ray S
Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
[TBL] [Abstract][Full Text] [Related]
8. Prevention of stroke in patients with patent foramen ovale.
Mattle HP; Meier B; Nedeltchev K
Int J Stroke; 2010 Apr; 5(2):92-102. PubMed ID: 20446943
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
10. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
[TBL] [Abstract][Full Text] [Related]
13. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
[TBL] [Abstract][Full Text] [Related]
14. Thrombus in transit within a patent foramen ovale: an argument for consideration of prophylactic closure?
Chow V; Wang W; Wilson M; Yiannikas J
J Clin Ultrasound; 2012 Feb; 40(2):115-8. PubMed ID: 21500200
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
[TBL] [Abstract][Full Text] [Related]
16. Indications, techniques and results of percutaneous patent foramen ovale closure.
Spies C; Hijazi ZM
Minerva Cardioangiol; 2012 Feb; 60(1):111-23. PubMed ID: 22322579
[TBL] [Abstract][Full Text] [Related]
17. Migraine, stroke and patent foramen ovale: a dangerous trio?
Butera G; Agostoni E; Biondi-Zoccai G; Bresolin N; Fumagalli L; Chessa M; Gallanti A; Scacciatela P; Carminati M
J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):233-8. PubMed ID: 18301138
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience.
Węglarz P; Konarska Kuszewska E; Spisak Borowska K; Machowski J; Drzewiecka-Gerber A; Kuszewski P; Jackson CL; Opala G; Trusz Gluza M
Kardiol Pol; 2012; 70(5):478-84. PubMed ID: 22623240
[TBL] [Abstract][Full Text] [Related]
19. Patent foramen ovale: clinical manifestations and treatment.
Kedia G; Tobis J; Lee MS
Rev Cardiovasc Med; 2008; 9(3):168-73. PubMed ID: 18953276
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
